HF
ENTX icon

HRT Financial’s Entera Bio ENTX Stock Holding History

HRT Financial’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
72,486
+56,994
+368% +$71.3K ﹤0.01% 3548
2026
Q1 		$17K Buy
+15,492
New +$21.7K ﹤0.01% 3586
2023
Q3 		– Sell
-26,414
Closed -$22K – 2574
2023
Q2 		$22K Buy
+26,414
New +$22.6K ﹤0.01% 2087
2023
Q1 		– Sell
-15,236
Closed -$11K – 2661
2022
Q4 		$11K Buy
+15,236
New +$11K ﹤0.01% 2215

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

HRT Financial's ENTX Position: Q2 2026 in Review

HRT Financial increased its Entera Bio (ENTX) stake by 368% in Q2 2026, buying an estimated $71.3K and bringing the position to 72,486 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3548.

HRT Financial first reported a position in ENTX in Q4 2022 and has held it in 4 quarters since. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • HRT Financial held 72,486 shares of Entera Bio worth $128K as of Q2 2026.
  • HRT Financial bought 56,994 Entera Bio shares in Q2 2026, an estimated $71.3K.
  • Entera Bio made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3548 holding.
  • HRT Financial first reported a position in Entera Bio in Q4 2022 and has held it in 4 quarters since.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.